Eli Lilly & Co.'s stock soared 14% Thursday, to put it on track for its biggest one-day gain in about 25 years, after the drugmaker reported positive results from a late-stage trial of a GLP-1 ...

The unofficial marijuana holiday, 4/20, is Sunday. Here are some commonly used marijuana terms to know before the weekend.

Below is a presentation of our financial results comparing FY 2024 to FY 2023, and are based on our results published in our Form 10-K filed with the SEC on April 15, 2025. Net income (loss) ...

As a human capital business, Insignia is exposed to ESG-specific risks like business ethics, product/corporate governance, and labor relations. The revelations of advisor misconduct or conflicted ...

But this one, for Lilly’s first diabetes and weight-loss pill based on the GLP-1 hormone, was particularly fraught. Days ...

Avicanna Inc. ("Avicanna" or the "Company) , a biopharmaceutical company focused on the development, manufacturing, and commercialization of plant-derived cannabinoid-based products, is pleased to ...

Even if you don’t receive an offer, it’s still possible you may get approved when you apply if ... to see if you’re prequalified via a form on its website. Interested customers can also ...

If a product that has orphan drug designation subsequently receives the first FDA approval for the disease or condition for ... including Scilex’s Annual Report on Form 10-K for the year ended ...

(The Center Square) – A nonprofit public-interest litigation firm filed a lawsuit Monday alleging President Donald Trump's "Liberation Day" tariffs require congressional approval ... the five ...

Read about President Trump's executive order directing agencies to prioritize buying commercially available products and ...

Regeneron Pharmaceuticals and Sanofi won U.S. Food and Drug Administration expanded approval of their blockbuster anti-inflammatory drug Dupixent for the inflammatory skin condition chronic ...